Italfarmaco

Italfarmaco, one of the leading Italian pharmaceutical groups, operates in both the pharmaceutical and the fine chemical industries.

President of Italfarmaco Holding is Francesco De Santis has been involved with Italfarmaco since 1981. He has personally driven the foundation and internationalization process of all of the group’s companies.The Italfarmaco Group now markets ethical products in Italy, Switzerland, Spain, Portugal, Greece, Russia, Turkey, Chile, Peru, Morocco and also for the subsidiary Chemi SPA in USA and Brazil. The company employs more than 2100 and total turnover exceeds 500 million euros.

Its products, all of which have a high therapeutic content, are mainly used in the cardiovascular, immuno-oncological, gynaecological, dermatological, orthopaedic and neurological areas.